Abstract

Mycoplasma pneumoniae (M. pneumoniae) frequently causes community-acquired respiratory tract infection and often presents as atypical pneumonia. Following airborne infection and a long incubation period, affected patients mostly suffer from mild or even asymptomatic and self-limiting disease. In particular in school-aged children, M. pneumoniae is associated with a wide range of extrapulmonary manifestations including central nervous system (CNS) disease. In contrast to children, severe CNS manifestations are rarely observed in adults. We report a case of a 37 year-old previously healthy immunocompetent adult with fulminant M. pneumoniae-induced progressive encephalomyelitis who was initially able to walk to the emergency department. A few hours later, she required controlled mechanical ventilation for ascending transverse spinal cord syndrome, including complete lower extremity paraplegia. Severe M. pneumoniae-induced encephalomyelitis was postulated, and antimicrobial, anti-inflammatory and immunosuppressive therapy was applied on the intensive care unit. Despite early and targeted therapy using four different immunosuppressive strategies, clinical success was limited. In our patient, locked-in syndrome developed followed by persistent minimally conscious state. The neurological status was unchanged until day 230 of follow-up. Our case underlines that severe M. pneumoniae- related encephalomyelitis must not only be considered in children, but also in adults. Moreover, it can be fulminant and fatal in adults. Our case enhances the debate for an optimal antimicrobial agent with activity beyond the blood–brain barrier. Furthermore, it may underline the difficulty in clinical decision making regarding early antimicrobial treatment in M. pneumoniae disease, which is commonly self-limited.

Highlights

  • Mycoplasma pneumoniae (M. pneumoniae) is a small bacterium that lacks a rigid cellular wall. It is considered highly contagious and airborne infection may result in atypical pneumonia following a longer incubation period (Waites and Talkington 2004; Waites and Atkinson 2009)

  • M. pneumoniae-induced atypical pneumonia can be treated in an outpatient setting and the clinical course is commonly mild and self-limiting or even asymptomatic (Spuesens 2014)

  • In particular in school-aged children (Christie et al 2007), M. pneumoniae is associated with a wide range

Read more

Summary

Introduction

Mycoplasma pneumoniae (M. pneumoniae) is a small bacterium that lacks a rigid cellular wall. M. pneumoniae-induced atypical pneumonia can be treated in an outpatient setting and the clinical course is commonly mild and self-limiting or even asymptomatic (Spuesens 2014). *Correspondence: joerg.schefold@insel.ch 2 Department of Intensive Care Medicine, Inselspital, Bern University Hospital, 3010 Bern, Switzerland Full list of author information is available at the end of the article of extrapulmonary manifestations including mucocutaneous and central nervous system (CNS) disease. In few cases severe encephalomyelitis develops (Waites and Talkington 2004; Christie et al 2007; Daxboeck 2006; Granerod et al 2010; Tsiodras et al 2005; Atkinson and Waites 2014).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.